Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Experimental analysis of sources of error in evolutionary studies based on Roche/454 pyrosequencing of viral genomes.

Ericka A Becker | Charles M Burns | Enrique J León | Saravanan Rajabojan | Robert Friedman | Thomas C Friedrich | Shelby L O'Connor | Austin L Hughes
Genome biology and evolution | 2012

Factors affecting the reliability of Roche/454 pyrosequencing for analyzing sequence polymorphism in within-host viral populations were assessed by two experiments: 1) sequencing four clonal simian immunodeficiency virus (SIV) stocks and 2) sequencing mixtures in different proportions of two SIV strains with known fixed nucleotide differences. Observed nucleotide diversity and frequency of undetermined nucleotides were increased at sites in homopolymer runs of four or more identical nucleotides, particularly at AT sites. However, in the mixed-strain experiments, the effects on estimated nucleotide diversity of such errors were small in comparison to known strain differences. The results suggest that biologically meaningful variants present at a frequency of around 10% and possibly much lower are easily distinguished from artifacts of the sequencing process. Analysis of the clonal stocks revealed numerous rare variants that showed the signature of purifying selection and that elimination of variants at frequencies of less than 1% reduced estimates of nucleotide diversity by about an order of magnitude. Thus, using a 1% frequency cutoff for accepting a variant as real represents a conservative standard, which may be useful in studies that are focused on the discovery of specific mutations (such as those conferring immune escape or drug resistance). On the other hand, if the goal is to estimate nucleotide diversity, an optimal strategy might be to include all observed variants (even those at less than 1% frequency), while masking out homopolymer runs of four or more nucleotides.

Pubmed ID: 22436995

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM043940
  • Agency: NCRR NIH HHS, United States
    Id: RR020141-01
  • Agency: NIGMS NIH HHS, United States
    Id: GM43940
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI077376
  • Agency: NIAID NIH HHS, United States
    Id: AI077376
  • Agency: NCRR NIH HHS, United States
    Id: RR000167
  • Agency: NIH HHS, United States
    Id: P51 OD011106
  • Agency: NCRR NIH HHS, United States
    Id: C06 RR020141
  • Agency: NCRR NIH HHS, United States
    Id: C06 RR015459
  • Agency: NCRR NIH HHS, United States
    Id: P51 RR000167
  • Agency: NCRR NIH HHS, United States
    Id: RR15459-01

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Vero (tool)

RRID:CVCL_0059

Cell line Vero is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions